The europe radiotherapy patient positioning market was valued at over US$ 120.3 million in 2021, and it is projected to rise at a compound yearly growth rate (CAGR) of over 4.1% between 2022 and 2032, according to the most recent updated industry report by Future Market Insights.
Cancer is the second largest cause of mortality followed by cardiovascular diseases in Europe. Approximately 2.9 million people are diagnosed with cancer, of which about 1.2 million cases account for mortality. The high rate of mortality associated with the increasing prevalence of cancer within the region has an impact on both social and economic levels.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14727
On average, around 40% of cancers are preventable after proper treatment assessment. This increase in the number of cases can boost the market by demining more radiotherapy patient positioning devices. Hence Euro commission focuses on prevention, early detection, diagnosis and treatment, and improving the quality of life of cancer patients and survivors.
Also, emergence of the immobilization system has made cancer detection easy and cancer management is done in an appropriate manner. This is propelling the growth of the Europe radiotherapy patient positioning market.
Europe patient positioning market is highly fragmented. New products are continually being introduced into the market by companies. Furthermore, key players are working hard to create innovative treatments and therapies and obtain regulatory clearances in order to enhance patient outcomes in the region.
Key Takeaways:
- Markers as products are expected to hold over 27.0%market value share by the end of 2032 and are expected to display a CAGR growth of 3.1% over the forecast period.
- Radiation/proton therapy centers hold a higher end-user segment share in terms of the market share value of 45.1% in 2021.
- DACH is slated to be the largest leading region with a value share of 18.5% in 2021, owing to the high prevalence of lung cancer within the country.
“Rising incidences of cancer and growing awareness in cancer management are set to boost the sales of radiotherapy patient positioning market,” says an analyst of Future Market Insights.
Market Competition
Key manufacturers are actively working in coherence with researchers in order to be able to acquire enhanced and innovative concepts to widen the therapeutic actions of the product that drive their research capabilities and strengthen their product portfolio.
Further, these players are also focusing on activities related to acquisitions and agreements in order to expand the product reach.
- In Jan 2022, Eckert & Ziegler acquired 100% of the shares of Argentinian nuclear medicine specialist Tecnonuclear S. A., a manufacturer of Technetium-99 generators and a portfolio of related biomolecules.
- In Oct 2021, Roper Technologies, Inc., did an agreement to sell its CIVCO Radiotherapy business to an affiliate of Blue Wolf Capital Partners LLC, a private equity firm, in an all-cash transaction valued at $120 million. Roper will retain its CIVCO Medical Solutions business, which will continue to operate independently.
What Does the Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the Radiotherapy Patient Positioning Market in its latest study, presenting a historical demand assessment for 2017 – 2021 and projections for 2022 – 2032.
The research study is based on the product (thermoplastic masks & sheets, markers, immobilization system, headrest, cushions, spacers & wedges, arm & wrist support, locating & indexing bar, bite positioners), by end user (hospitals, cancer research institutes and radiation/proton therapy centres) across Europe.
Unlock exclusive insights with our expert analysts:
https://www.futuremarketinsights.com/ask-question/rep-gb-14727
Key Companies:
- Orfit Industries
- Qfix
- Elekta
- Eckert & Ziegler BEBIG
- CDR Systems
- Roper Technologies-CIVCO
- Best Medical Canada
- Blessing Cathay Corporation
- Candor ApS
- IZI Medical Products
- Klarity Medical Products
- MacroMedics BV
- OSL Oncology Systems Limited.
- T-Tape Company B.V.
Key Segments :
By Product Type:
- Thermoplastic Masks & Sheets
- Head Masks
- Head & Shoulder Masks
- Torso & Extremities
- Markers
- Fiducial Markers
- Vaginal Markers
- Rectal Marker
- Immobilization System
- Head Rest
- Cushions
- Spacers & Wedges
- Arm & Wrist Support
- Locating & Indexing Bar
- Bite Positioners
By End User:
- Hospitals
- Cancer Research Institutes
- Radiation/Proton Therapy Centres
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
